Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune deficiency syndrome (HIV infection)

摘要

The invention relates to a pharmaceutical composition for the treatment of a human having acquired immune deficiency syndrome caused by HIV-infection comprising the cell suspension from either the liver, the spleen, or both, of a single human embryo.